Breathe Well Live Well
|
Antibody Gets High Marks for Asthma Control
MedPage Today "This study targeted those individuals who, on the basis of eosinophil levels in their blood, seemed to have evidence for Th2-type asthma," principal investigator Sally Wenzel, MD, of the University of Pittsburgh, told MedPage Today. "By using this … |
View full post on asthma – Google News
|
Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa Trial
Science 2.0 A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to researchers. The randomized, double-blind, placebo-controlled trial tested the efficacy … |
View full post on asthma – Google News
 Examiner.com |
Monoclonal Antibody Works in Severe Asthma
MedPage Today Note that a multicenter, randomized placebo-controlled trial found that mepolizumab, a monoclonal antibody against interleukin-5, decreased asthma exacerbations, hospitalizations, and emergency department visits for patients with severe asthma and … Clinical study: New asthma drug cuts attack frequency in half GSK severe asthma drug progresses to Phase III GSK asthma drug cuts symptoms 52%; ready for PhIII |
View full post on asthma – Google News
|
Humanized Monoclonal Antibody May Be Effective, Safe in Asthma Patients
Medscape January 11, 2011 — Add-on therapy with subcutaneous omalizumab is safe and effective in patients with moderate to severe allergic asthma, according to the … |
View full post on asthma – Google News
|
ACAAI: Antibody Shows Benefit in Asthma Subtype
MedPage Today Note that there was a trend toward statistical significance regarding the clinical outcome of asthma control. PHOENIX – An investigational monoclonal … ACAAI: Obesity Linked to Asthma Among Allergic Patients ACAAI: Mild Asthma Often Over-Treated |
View full post on asthma – Google News
|
Antibody Linked to Allergies on the Rise
U.S. News & World Report The findings are to be presented Saturday at the American College of Allergy, Asthma and Immunology annual meeting, in Phoenix. Jacobs and his colleagues … |
View full post on asthma – Google News